A New Therapeutic Strategy for Advanced Squamous Cell Carcinomas of the Head and Neck
Pp. 3-11 (9)
Haruo Hirakawa, Yasuyuki Nishi, Taisuke Watanabe, Makoto Tada, Kiyomi Taniyama and Wataru Kamiike
A concurrent superselective intra-arterial chemoradiotherapy (SIACRT) is a
new therapeutic strategy for advanced squamous cell carcinomas of the maxillary sinus
and upper gingiva that might enable patients to keep the shape and function as well as
improve curability. We have been applying SIACRT since 2008. We will present the
results of SIACRT compared to conventional combined therapy at our hospital.
SIACRT is promising to preserve patient’s quality of life (QOL) both under and after
the treatment without sacrificing a cure rate.
Cisplatin, Head and neck cancer, Superselective intra-arterial
Department of Otorhinolaryngology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.